Mimori K - Search Results

1

Novel oncogene 5MP1 reprograms c-Myc translation initiation to drive malignant phenotypes in colorectal cancer.

Sato K, Masuda T, Hu Q, Tobo T, Gillaspie S, Niida A, Thornton M, Kuroda Y, Eguchi H, Nakagawa T, Asano K, Mimori K. Sato K, et al. Among authors: mimori k. EBioMedicine. 2019 Jun;44:387-402. doi: 10.1016/j.ebiom.2019.05.058. Epub 2019 Jun 4. EBioMedicine. 2019. PMID: 31175057 Free PMC article.

2

Localization of thymidine phosphorylase expression in colorectal carcinoma tissues by in situ RT-PCR assay.

Mimori K, Matsuyama A, Yoshinaga K, Yamashita K, Masuda T, Inoue H, Ueo H, Mori M. Mimori K, et al. Oncology. 2002;62(4):327-32. doi: 10.1159/000065064. Oncology. 2002. PMID: 12138240

3

MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway.

Mimori K, Shiraishi T, Mashino K, Sonoda H, Yamashita K, Yoshinaga K, Masuda T, Utsunomiya T, Alonso MA, Inoue H, Mori M. Mimori K, et al. Oncogene. 2003 May 29;22(22):3463-71. doi: 10.1038/sj.onc.1206378. Oncogene. 2003. PMID: 12776198

4

N-cadherin is regulated by activin A and associated with tumor aggressiveness in esophageal carcinoma.

Yoshinaga K, Inoue H, Utsunomiya T, Sonoda H, Masuda T, Mimori K, Tanaka Y, Mori M. Yoshinaga K, et al. Among authors: mimori k. Clin Cancer Res. 2004 Sep 1;10(17):5702-7. doi: 10.1158/1078-0432.CCR-03-0262. Clin Cancer Res. 2004. PMID: 15355896

5

Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients.

Masuda TA, Kataoka A, Ohno S, Murakami S, Mimori K, Utsunomiya T, Inoue H, Tsutsui S, Kinoshita J, Masuda N, Moriyama N, Mori M. Masuda TA, et al. Among authors: mimori k. Int J Oncol. 2005 Mar;26(3):721-30. Int J Oncol. 2005. PMID: 15703829

6

[Occult micrometastasis].

Masuda T, Mimori K, Mori M. Masuda T, et al. Among authors: mimori k. Nihon Rinsho. 2006 Mar;64(3):442-9. Nihon Rinsho. 2006. PMID: 16529034 Review. Japanese.

7

Clinical significance of growth differentiation factor 11 in colorectal cancer.

Yokoe T, Ohmachi T, Inoue H, Mimori K, Tanaka F, Kusunoki M, Mori M. Yokoe T, et al. Among authors: mimori k. Int J Oncol. 2007 Nov;31(5):1097-101. Int J Oncol. 2007. PMID: 17912435

8

PDGF-BB is a novel prognostic factor in colorectal cancer.

Nakamura Y, Tanaka F, Yoshikawa Y, Mimori K, Inoue H, Yanaga K, Mori M. Nakamura Y, et al. Among authors: mimori k. Ann Surg Oncol. 2008 Aug;15(8):2129-36. doi: 10.1245/s10434-008-9943-9. Epub 2008 May 14. Ann Surg Oncol. 2008. PMID: 18478301

9

Over- and under-expressed microRNAs in human colorectal cancer.

Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K, Mori M. Motoyama K, et al. Among authors: mimori k. Int J Oncol. 2009 Apr;34(4):1069-75. doi: 10.3892/ijo_00000233. Int J Oncol. 2009. PMID: 19287964

10

Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance.

Iwatsuki M, Mimori K, Ishii H, Yokobori T, Takatsuno Y, Sato T, Toh H, Onoyama I, Nakayama KI, Baba H, Mori M. Iwatsuki M, et al. Among authors: mimori k. Int J Cancer. 2010 Apr 15;126(8):1828-1837. doi: 10.1002/ijc.24879. Int J Cancer. 2010. PMID: 19739118

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

514 results

Search Page

Filters